rss
1

Australian cleantech stocks continue to outperform main indices

Print Friendly
Shuttershock

Shuttershock

Australian CleanTech Index again outperformed the ASX200 for both the month and the quarter.

The Australian CleanTech Index rose from 42.94 to 44.57 over the month of December recording a 3.8% gain. This compared to the ASX200 gain of 2.5% and the ASX Small Ordinaries Index gain of 3.6%. The Australian CleanTech 20 also recorded a gain of 3.8%.

Over the second quarter of the 2016 fiscal year, the Australian CleanTech Index recorded a gain of 6.9%, ahead the ASX200’s gain of 5.5% but lagging the ASX Small Ordinaries’ 10.8% gain.

The six and twelve month figures also remain well ahead of the ASX200 but are now lagging the ASX Small Ordinaries. Over the last 3 years, the Australian CleanTech Index recorded a gain of 39.6%, 26.2% ahead of the ASX200.

The market capitalisation after its rebalance of the 62 stocks in the Australian CleanTech Index is A$16.9 billion.

Best and Worst Stocks

The best and worst performers in terms of share price performance over the month and the quarter are shown in the table below.

The month’s performance was driven by 5 companies with gains of more than 15%. The greatest percentage gains were recorded by GO Energy Group (GOE), Intec (INL) and Neometals (NMT). These gains were partially offset by 14 companies recording losses of more than 15% led by Soil Sub Technologies (SOI), Water Resources Group (WRG), AnaeCo (ANQ) and Enerji (ERJ).

The quarter’s performance was driven by 9 companies with gains of more than 20%. The greatest gains were recorded by Vmoto (VMT), Eden Energy (EDE) and Australian Renewable Fuels (ARW). These gains were partially offset by 17 companies recording losses of more than 20% led by EcoSave (ECV), Enerji (ERJ) and AnaeCo (ANQ).

rsz_screen_shot_2016-01-11_at_122440_pm

rsz_screen_shot_2016-01-11_at_123634_pm-2
RenewEconomy Free Daily Newsletter

Share this:

  • Rikaishi Rikashi

    Pretty nice results given the hit-job that the government has been performing on them. Or maybe this is the post-Abbott recovery.